Clinical Trials Logo

Clinical Trial Summary

The method comparison study involves capillary fingerstick blood, venous serum, and venous K2EDTA blood sample collection from human subjects receiving clozapine treatment and their clozapine concentration measurement using a validated mass spectrometry method, the automated immunoassay MyCare Psychiatry Clozapine Assay Kit manufactured by SBI, and the point of care MyCare Insite Clozapine Test manufactured by SBI. Clozapine measurements obtained using the MyCare Insite Clozapine Test are intended for investigational purposes only and shall not be used in the management of patients receiving clozapine therapy.


Clinical Trial Description

n/a


Study Design


NCT number NCT05422131
Study type Observational
Source Saladax Biomedical, Inc.
Contact
Status Completed
Phase
Start date November 12, 2022
Completion date May 16, 2023